Annals of Neurology

Papers
(The H4-Index of Annals of Neurology is 47. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
222
Reply to “Urinary α‐Synuclein for Parkinson's Detection: Key Limitations and Future Directions”194
Issue Information138
128
Efficacy and Safety of Ofatumumab Treatment for Anti‐NMDA Receptor Autoimmune Encephalitis (OFFAE): A Prospective, Multicenter Cohort Study124
Elevated Cerebrospinal Fluid Ubiquitin Carboxyl‐Terminal Hydrolase Isozyme L1 in Asymptomatic C9orf72 Hexanucleotide Repeat Expansion Carriers104
HLA Associations of Intrathecal IgG Production against Specific Viruses in Multiple Sclerosis99
Vertebral Artery Pseudoaneurysm: Novel Marker of Bow Hunter's Syndrome99
98
Annals of Neurology: Volume 97, Number 1, January 202594
Carotid Stent Fracture89
Microneurography Reveals Unmyelinated Small Nerve Fiber Dysfunction in Long COVID88
Cerebrospinal Fluid Flow in Patients with Huntington's Disease83
Network Localization of Awareness in Visual and Motor Anosognosia82
Interactions between High Seroreactivity to Human Herpes Virus 6A and Epstein–Barr Virus in MS Development: A Presymptomatic Case–Control Study81
Furthering Female Faculty: An American Neurological Association/Association of University Professors of Neurology Perspective81
A Letter Concerning a Role for Blood–Brain Barrier Dysfunction in Delirium following Noncardiac Surgery in Older Adults81
Association of Retromer Deficiency and Tau Pathology in Down Syndrome79
Supratentorial Lymphocytic Inflammation with Parenchymal Perivascular Enhancement Responsive to Steroids: A Potentially Overlooked Diagnosis79
Septin‐5 and ‐7‐IgGs: Neurologic, Serologic, and Pathophysiologic Characteristics76
Epidemiology, Survival, and Clinical Characteristics of Inclusion Body Myositis76
Biological Age Acceleration and Motoric Cognitive Risk Syndrome75
Before, during, and after: An Argument for Safety and Improved Outcome of Thrombolysis in Acute Ischemic Stroke with Direct Oral Anticoagulant Treatment73
Management of Cerebral Venous Thrombosis Due to Adenoviral COVID‐19 Vaccination66
Cortical Microhemorrhage Presentation of Small Vessel Primary Angiitis of the Central Nervous System62
The Use of Antihypertensive Medication and In Vivo Alzheimer's Disease Pathology62
Prevalence of Cerebral Amyloid Angiopathy and Associated Risk of Subsequent Ischemic and Hemorrhagic Stroke and Mortality in a Nationwide Cohort62
A Managed Care System with Telemedicine Support for Neurological Emergencies61
Frailty across Neurological Diseases: Why Sex and Gender Matter60
MS ‐Driven Metabolic Alterations Are Recapitulated in iPSC ‐Derived Astrocytes60
Probabilistic Mapping Reveals Optimal Stimulation Site in Essential Tremor58
Diet, Pace of Biological Aging, and Risk of Dementia in the Framingham Heart Study57
Staufen Impairs Autophagy in Neurodegeneration56
A Role for Insulin‐like Growth Factor 1 in the Generation of Epileptic Spasms in a murine model56
Guanylate Kinase 1 Deficiency: A Novel and Potentially Treatable Mitochondrial DNA Depletion/Deletions Disease55
Plasma Metabolites Link Dietary Patterns to Stroke Risk55
Blood Pressure after Successful Endovascular Therapy: A Systematic Review and Meta‐Analysis of Randomized Control Trials53
Dysregulation of Gut Microbiota‐Derived Neuromodulatory Amino Acid Metabolism in Human Immunodeficiency Virus‐Associated Neurocognitive Disorder: An Integrative Metagenomic and Metabolomic 52
Effect of Imaging Markers on Reperfusion Therapy in Basilar Artery Occlusion52
Severity of GNAO1‐Related Disorder Correlates with Changes in G‐Protein Function51
Suvorexant Acutely Decreases Tau Phosphorylation and Aβ in the Human CNS50
Annals of Neurology: Volume 94, Number S30, September 202349
Cover Image49
Issue Information49
Longitudinal Imaging Biomarkers Correlate with Progressive Motor Deficit in the Mouse Model of Charlevoix‐Saguenay Ataxia48
MEK Pathway Inhibitor‐Mediated Response in BRAF V600‐Mutant Melanoma with Brain Parenchymal and Leptomeningeal Metastases47
Sports Concussion and Category Mistakes47
0.14212107658386